Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
2022-02-14 5:10 pm Sale | 13G | CONSONANCE-HFW ACQUISITION COR CHFWU | BRIDGER MANAGEMENT LLC | 0 0% | -700,000 (Position Closed) | View |
2021-02-16 4:23 pm Sale | 13G | ATARA BIOTHERAPEUTICS INC ATRA | BRIDGER MANAGEMENT LLC | 1,524,760 1.8% | -1,408,105 (-48.01%) | View |
2020-11-30 4:15 pm Purchase | 13G | CONSONANCE-HFW ACQUISITION COR CHFWU | BRIDGER MANAGEMENT LLC | 700,000 8.8% | 700,000 (New Position) | View |
2020-02-14 4:34 pm Unchanged | 13G | DICERNA PHARMACEUTICALS INC CO DRNA | BRIDGER MANAGEMENT LLC | 1,981,633 2.9% | 0 (Unchanged) | View |
2020-02-14 4:04 pm Sale | 13G | DICERNA PHARMACEUTICALS INC CO DRNA | BRIDGER MANAGEMENT LLC | 1,981,633 2.9% | -2,792,085 (-58.49%) | View |
2020-02-14 4:00 pm Unchanged | 13G | ATARA BIOTHERAPEUTICS INC ATRA | BRIDGER MANAGEMENT LLC | 2,932,865 5.4% | 0 (Unchanged) | View |
2020-02-14 4:00 pm Sale | 13G | TG THERAPEUTICS, INC. TGTX | BRIDGER MANAGEMENT LLC | 1,907,492 1.9% | -3,084,039 (-61.79%) | View |
2019-11-01 4:12 pm Purchase | 13G | ATARA BIOTHERAPEUTICS INC ATRA | BRIDGER MANAGEMENT LLC | 2,932,865 5.5% | 725,948 (+32.89%) | View |